THE LIAISON GROUP, LLC for ACREAGE HOLDINGS
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Building support for, and securing enactment of, bipartisan legislation allowing states to set and enforce their own laws governing cannabis use; Removing federal restrictions that prohibit medical research involving cannabis to encourage the development of solutions that can improve the lives of veterans and patients and combat the opioid epidemic in the United States; Allowing companies operating legally in the cannabis industry to utilize traditional institutions for financial transactions; and Correcting flaws in the US tax code that serve as barriers to legal commerce in the cannabis space and slow the development of solutions that can improve Americans lives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB New | — |
Banking BAN
Building support for, and securing enactment of, bipartisan legislation allowing states to set and enforce their own laws governing cannabis use; Removing federal restrictions that prohibit medical research involving cannabis to encourage the development of solutions that can improve the lives of veterans and patients and combat the opioid epidemic in the United States; Allowing companies operating legally in the cannabis industry to utilize traditional institutions for financial transactions; and Correcting flaws in the US tax code that serve as barriers to legal commerce in the cannabis space and slow the development of solutions that can improve Americans lives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB New | — |
Financial Institutions/Investments/Securities FIN
Building support for, and securing enactment of, bipartisan legislation allowing states to set and enforce their own laws governing cannabis use; Removing federal restrictions that prohibit medical research involving cannabis to encourage the development of solutions that can improve the lives of veterans and patients and combat the opioid epidemic in the United States; Allowing companies operating legally in the cannabis industry to utilize traditional institutions for financial transactions; and Correcting flaws in the US tax code that serve as barriers to legal commerce in the cannabis space and slow the development of solutions that can improve Americans lives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB New | — |
Taxation/Internal Revenue Code TAX
Building support for, and securing enactment of, bipartisan legislation allowing states to set and enforce their own laws governing cannabis use; Removing federal restrictions that prohibit medical research involving cannabis to encourage the development of solutions that can improve the lives of veterans and patients and combat the opioid epidemic in the United States; Allowing companies operating legally in the cannabis industry to utilize traditional institutions for financial transactions; and Correcting flaws in the US tax code that serve as barriers to legal commerce in the cannabis space and slow the development of solutions that can improve Americans lives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB New | — |
Veterans VET
Building support for, and securing enactment of, bipartisan legislation allowing states to set and enforce their own laws governing cannabis use; Removing federal restrictions that prohibit medical research involving cannabis to encourage the development of solutions that can improve the lives of veterans and patients and combat the opioid epidemic in the United States; Allowing companies operating legally in the cannabis industry to utilize traditional institutions for financial transactions; and Correcting flaws in the US tax code that serve as barriers to legal commerce in the cannabis space and slow the development of solutions that can improve Americans lives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB New | — |
Consumer Issues/Safety/Products CSP
Building support for, and securing enactment of, bipartisan legislation allowing states to set and enforce their own laws governing cannabis use; Removing federal restrictions that prohibit medical research involving cannabis to encourage the development of solutions that can improve the lives of veterans and patients and combat the opioid epidemic in the United States; Allowing companies operating legally in the cannabis industry to utilize traditional institutions for financial transactions; and Correcting flaws in the US tax code that serve as barriers to legal commerce in the cannabis space and slow the development of solutions that can improve Americans lives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB New | — |
Medical/Disease Research/Clinical Labs MED
Building support for, and securing enactment of, bipartisan legislation allowing states to set and enforce their own laws governing cannabis use; Removing federal restrictions that prohibit medical research involving cannabis to encourage the development of solutions that can improve the lives of veterans and patients and combat the opioid epidemic in the United States; Allowing companies operating legally in the cannabis industry to utilize traditional institutions for financial transactions; and Correcting flaws in the US tax code that serve as barriers to legal commerce in the cannabis space and slow the development of solutions that can improve Americans lives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHAEL GALOOB New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.